ytracis
cis bio international - yttrium (90y) chloride - radionukliidi pildistamine - diagnostilised radiofarmatseutilised ühendid - kasutada ainult spetsiaalselt välja töötatud ja radioloogilise märgistamise jaoks selle radionukliidiga kandev-molekulide radiomärgistamiseks. radiopharmaceutical precursor - not intended for direct application to patients.
yttriga
eckert ziegler radiopharma gmbh - yttrium (90y) chloride - radionukliidi pildistamine - diagnostilised radiofarmatseutilised ühendid - kasutada ainult kandermolekulide radiomärgistamiseks, mis on spetsiaalselt välja töötatud ja lubatud selle radionukliidiga radiomärgistamiseks. radiofarmatseutilisi eelkäija - mis ei ole ette nähtud otseseks kasutamiseks patsientidel,.
yttrium (90-y) colloid suspension ymm-1 süstesuspensioon
iba molecular - ütrium(90y)tsitraat, kolloidne - süstesuspensioon - 370mbq 1ml 1ml 1tk
sodium chloride kabi 0,9% süsteravimi lahusti
fresenius kabi polska sp. z o.o. - naatriumkloriid - süsteravimi lahusti - 9mg 1ml 10ml 50tk; 9mg 1ml 20ml 20tk; 9mg 1ml 5ml 20tk; 9mg 1ml 5ml 50tk
sodium chloride braun 5,85% infusioonilahuse kontsentraat
b. braun melsungen ag - naatriumkloriid - infusioonilahuse kontsentraat - 5,85% 20ml 20tk
sodium chloride b. braun 0,9% süstelahus
b. braun melsungen ag - naatriumkloriid - süstelahus - 0,9% 1ml 10ml 20tk; 0,9% 1ml 10ml 50tk; 0,9% 1ml 20ml 20tk; 0,9% 1ml 100ml 20tk; 0,9% 1ml 20ml 100tk; 0,9% 1ml 50ml 20tk; 0,9% 1ml 20ml 50tk
lutetium (177lu) chloride billev (previously illuzyce)
billev pharma aps - lutetium (177lu) chloride - radionukliidi pildistamine - terapeutilised radiofarmatseutilised ühendid - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , kolmekordne kombineeritud ravi) lisandina toitumise ja treeningu patsientidel, ebapiisavalt kontrollitud nende maksimaalne talutav annus metformiin ja sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
potassium chloride/sodium chloride fresenius infusioonilahus
fresenius kabi deutschland gmbh - kaaliumkloriid+naatriumkloriid - infusioonilahus - 1,5mg+9mg 1ml 500ml 10tk
potassium chloride/sodium chloride fresenius infusioonilahus
fresenius kabi deutschland gmbh - kaaliumkloriid+naatriumkloriid - infusioonilahus - 3mg+9mg 1ml 1000ml 10tk